Mesenchymal stem cell therapy in cats: Current knowledge and future potential

@article{Quimby2018MesenchymalSC,
  title={Mesenchymal stem cell therapy in cats: Current knowledge and future potential},
  author={Jessica M Quimby and Dori L Borjesson},
  journal={Journal of Feline Medicine and Surgery},
  year={2018},
  volume={20},
  pages={208 - 216}
}
Practical relevance: Stem cell therapy is an innovative field of scientific investigation with tremendous potential for clinical application in veterinary medicine. Based on the known desirable immunomodulatory properties of mesenchymal stem cells, this therapy holds promise for the treatment of a variety of inflammatory diseases in cats. Aims: This review details our current understanding of feline stem cell biology and proposed mechanism of action. Studies performed in feline clinical trials… Expand
Mesenchymal stem cells therapy in companion animals: useful for immune-mediated diseases?
TLDR
Although mesenchymal stem cells present a promising future in the treatment of most of these disorders, the variability in the outcomes of some clinical trials has led to the current controversy among authors regarding their efficacy. Expand
Adult Stem Cells Based Therapies in Veterinary Medicine
TLDR
Overall data indicate that particularly the umbilical cord MSC (UC MSC) therapy which involves the most primitive MSCs may bring considerable benefits to patients with a wide range of diseases. Expand
Proteomic Analysis of the Secretome and Exosomes of Feline Adipose-Derived Mesenchymal Stem Cells
TLDR
The objective of this study was to determine and compare the protein profile of the secretome as a whole and its exosomal fraction from feline adipose-derived MSCs (fAd-MSCs) to understand better the mechanisms of action of these components and facilitate their possible use in future therapies. Expand
Safety and immunomodulatory properties of equine peripheral blood-derived mesenchymal stem cells in healthy cats.
TLDR
This preliminary study demonstrates that ePB-MSCs can safely be administered in healthy cats and provide a promising alternative for the treatment of various inflammatory diseases in cats. Expand
Animal Stem Cells—A Perspective on Their Use in Human Health
TLDR
Improved cell culture techniques, culture media, and supplements, insights into gene-environmental interactions may solve current bottlenecks associated with segregation, description, and applications of stem cells in livestock. Expand
Concise Reviews: Stem Cells and Kidney Regeneration: An Update
TLDR
It is proposed that harmonized rigorous protocols for characterization, handling, and delivery of stem cells in vivo could significantly advance the field, and details of some suggested approaches to foster translation in the field of renal regeneration are presented. Expand
Cat Mesenchymal Stem Cell Characteristics and Potential Applications
TLDR
Cat mesenchymal stem cells (fMSCs) characteristics and their potential applications are discussed. Expand
Extracellular vesicles derived from mesenchymal stem cells as a potential therapeutic agent in acute kidney injury (AKI) in felines: review and perspectives
TLDR
The significance of the processes, in whose EVs are included during the AKI are underline in order to show the potential benefits of EVs-MSCs-based therapies against AKI in felines. Expand
Translational Animal Models Provide Insight Into Mesenchymal Stromal Cell (MSC) Secretome Therapy
The therapeutic potential of the mesenchymal stromal cell (MSC) secretome, consisting of all molecules secreted by MSCs, is intensively studied. MSCs can be readily isolated, expanded, andExpand
Mesenchymal stem cells for cartilage regeneration in dogs
TLDR
This review summarizes what is known about cMSCs, including their in vitro characteristics, their therapeutic effects in cartilage lesion treatment in preclinical in vivo studies, their clinical efficacy for treatment of naturally developed OA in dogs, and the current limitations of cMSC studies. Expand
...
1
2
...

References

SHOWING 1-10 OF 52 REFERENCES
Concise Review: Stem Cell Trials Using Companion Animal Disease Models
TLDR
Companion animals with naturally occurring diseases analogous to human conditions can be recruited into clinical trials and provide realistic insight into feasibility, safety, and biologic activity of novel stem cell therapies, however, improvements in the rigor of manufacturing, study design, and regulatory compliance will be needed to better utilize these models. Expand
Human and feline adipose-derived mesenchymal stem cells have comparable phenotype, immunomodulatory functions, and transcriptome
TLDR
Feline ASCs modulate lymphocyte proliferation using soluble mediators that mirror the human ASC secretion pattern, and have similar gene expression profiles to noninduced human ASCs. Expand
Mesenchymal stem cells as an immunomodulatory therapeutic strategy for autoimmune diseases.
TLDR
The documented immunomodulatory capabilities of the MSCs are discussed, the possible mechanisms underlying these functions are presented and the potential of using this stem cell-based approach as an immunommodulatory tool for the treatment of autoimmune diseases is presented. Expand
Evaluation of Immunomodulatory Properties of Feline Mesenchymal Stem Cells.
TLDR
Feline MSC have similar immunomodulatory gene expression and react to inflammatory cytokines in a manner similar to human MSC, suggesting that MSC may play an important role in treatment of feline disease as well as serve as an important translational species to evaluate MSC-based therapies of diseases common to both humans and cats. Expand
Feline foamy virus adversely affects feline mesenchymal stem cell culture and expansion: implications for animal model development.
TLDR
It is determined that the antiretroviral drug, tenofovir, may be used to support ex vivo expansion and salvage of FFV-infected fMSC lines, and that syncytial cell formation and proliferation arrest in fMSCs were caused by FFV strains that were highly homologous to previously reported FFVs. Expand
Therapeutic Efficacy of Fresh, Autologous Mesenchymal Stem Cells for Severe Refractory Gingivostomatitis in Cats
TLDR
The relative absence of CD8lo cells may be a biomarker to predict response to ASC therapy, and may shed light on pathogenesis of FCGS and mechanisms by which ASCs decrease oral inflammation and affect T‐cell phenotype. Expand
Therapeutic Efficacy of Fresh, Allogeneic Mesenchymal Stem Cells for Severe Refractory Feline Chronic Gingivostomatitis
TLDR
The administration of fresh, allogenic ASCs appeared to have lower clinical efficacy with a delayed response as compared to the fresh, autologous ASCs, and the mechanism(s) of action) may differ in this model of oral inflammation. Expand
Intravenous adipose-derived mesenchymal stem cell therapy for the treatment of feline asthma: a pilot study
TLDR
MSCs may have a delayed effect in reducing airway inflammation, airway hyper-responsiveness and remodeling in experimentally induced asthmatic cats, and warrant additional investigation of MSC therapy for asthma in cats. Expand
Stem cell therapy in cats with chronic enteropathy: a proof-of-concept study
TLDR
Although allogeneic adipose-derived fMSC therapy appears to be a safe and potentially effective treatment for cats suffering from chronic enteropathy, these preliminary results require significant follow-up study. Expand
Mesenchymal stromal cells and the innate immune response.
TLDR
What is known about the interactions of MSCs with cells of the innate immune system, how they respond to their microenvironment and how this relates to therapeutic effects the authors see both within in vivo animal models and in clinical trials are addressed. Expand
...
1
2
3
4
5
...